Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
13
HOOK Quote, Financials, Valuation and Earnings
Last price:
$1.14
Seasonality move
:
-19.92%
Day range:
$1.14 - $1.18
52-week range:
$0.72 - $6.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.53x
P/B ratio:
0.41x
Volume:
82.5K
Avg. volume:
63.2K
1-year change:
-82.73%
Market cap:
$13.9M
Revenue:
$43.9M
EPS (TTM):
-$5.84
Earnings Data
Next earnings date for HOOK
Aug 08
2025
Most recent earnings per share
-$1.23
Missed by $0.41
(May 15/2025)
Consensus Estimate
-$0.83
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HOOK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.66 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.64 | -- |
| 05/15/2025 | Q1 | $3.4M | $2M | -$1.23 | -$0.83 | -$0.41 |
| 03/21/2025 | Q4 | $6.5M | $1.4M | -$1.99 | -$0.69 | -$1.30 |
| 11/14/2024 | Q3 | $5M | $4.7M | -$1.10 | -$1.90 | $0.80 |
| 08/08/2024 | Q2 | $7.1M | $1.3M | -$1.52 | -$1.25 | -$0.27 |
| 05/09/2024 | Q1 | $5.2M | $36.6M | $1.14 | -$1.03 | $2.17 |
| 03/22/2024 | Q4 | $4.6M | $7.4M | -$2.22 | -$1.93 | -$0.30 |
| 11/09/2023 | Q3 | $4.3M | $6.9M | -$1.73 | -$2.04 | $0.31 |
| 08/10/2023 | Q2 | $4.8M | $2.7M | -$2.18 | -$2.14 | -$0.04 |
| 05/11/2023 | Q1 | -- | $3.2M | -$2.70 | -- | -- |
| 03/15/2023 | Q4 | -- | $7.8M | -$1.70 | -- | -- |
| 11/14/2022 | Q3 | -- | $2.2M | -$2.50 | -- | -- |
| 08/11/2022 | Q2 | -- | $2.7M | -$2.30 | -- | -- |
| 05/16/2022 | Q1 | -- | $1.4M | -$4.00 | -- | -- |
| 03/24/2022 | Q4 | -- | $3.9M | -$6.50 | -- | -- |
| 11/10/2021 | Q3 | -- | $3.9M | -$6.10 | -- | -- |
| 08/12/2021 | Q2 | -- | $5.4M | -$5.20 | -- | -- |
| 05/12/2021 | Q1 | -- | $5.3M | -$5.30 | -- | -- |
| 03/18/2021 | Q4 | -- | $5.2M | -$4.60 | -- | -- |
| 11/12/2020 | Q3 | -- | $4M | -$5.30 | -- | -- |
| 08/13/2020 | Q2 | -- | $6.7M | -$2.80 | -- | -- |
| 05/14/2020 | Q1 | -- | $3.7M | -$4.30 | -- | -- |
| 03/19/2020 | Q4 | -- | $3.6M | -$4.00 | -- | -- |
| 11/12/2019 | Q3 | -- | $2M | -$4.50 | -- | -- |
| 08/12/2019 | Q2 | -- | $4.1M | -$6.30 | -- | -- |
| 05/20/2019 | Q1 | -- | $2.2M | -$1.56 | -- | -- |
| 12/31/2018 | Q4 | -- | $5.1M | -$1.16 | -- | -- |
| 09/30/2018 | Q3 | -- | $1.9M | -$2.42 | -- | -- |
| 06/30/2018 | Q2 | -- | $649K | -$3.56 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$2.80 | -- | -- |
HOOKIPA Pharma Earnings Questions
-
How Much did HOOKIPA Pharma Generate in Revenue Last Quarter?
HOOKIPA Pharma reported $2M worth of top line sales in its most recent quarter.
-
Did HOOKIPA Pharma Beat Earnings Last Quarter?
HOOKIPA Pharma announced earnings per share of -$1.23 which represents a miss of analyst forecast a -$0.83 per share.
-
Is HOOKIPA Pharma Profitable?
HOOKIPA Pharma reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for HOOKIPA Pharma EPS Next Year?
HOOKIPA Pharma's earnings are forecast to decrease from -$3.47 per share to -$2.10 per share next year representing a decrease of -4.32%.
-
When is HOOKIPA Pharma's Earnings Date?
HOOKIPA Pharma's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
